'Improving the efficacy of PD-1 blockade through antibody engineering' & 'What we’ve learnt about T-cell signaling from novel immunotherapeutics'

OxTalks is Changing

OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.

If you have any questions, please contact halo@digital.ox.ac.uk

'Improving the efficacy of PD-1 blockade through antibody engineering' & 'What we’ve learnt about T-cell signaling from novel immunotherapeutics'
Attend in person or online via teams using the following link:
teams.microsoft.com/l/meetup-join/19%3ameeting_M2RhMzIzZmQtNDU0Mi00YjMwLWJhZTgtNDRlMjVkNWRjOWNh%40thread.v2/0?context=%7b%22Tid%22%3a%22cc95de1b-97f5-4f93-b4ba-fe68b852cf91%22%2c%22Oid%22%3a%2234a22e3a-3739-4011-9d09-ded6f9395a6b%22%7d
Date: 11 August 2023, 10:00
Venue: CAMS-COI meeting room (Behind the wellcome trust centre)
Speakers: Martin Fellermeyer, Mateusz Kotowski
Organiser contact email address: jordan.rolt@ndm.ox.ac.uk
Part of: Science in Progress (SIP) Talks
Booking required?: Not required
Audience: Public
Editor: Jordan Rolt